title: D-SAL and NAP: Two Peptides Sharing a SIP Domain.
abstract: NAPVSIPQ (NAP) and all D-amino acid SALLRSIPA (D-SAL) are neuroprotective peptides derived from activity-dependent neuroprotective protein (ADNP) and activity-dependent neurotrophic factor (ADNF), respectively. Both proteins were shown to protect against cognitive impairment, using different animal models and to increase neuronal survival following exposure to neurotoxins. NAP was extensively tested and found to increase microtubule stability, protect axonal transport, and inhibit apoptosis. Here, we aimed to further evaluate and correlate effects at the behavioral level, in a rat model of diabetes. Diabetes is primarily a metabolic disorder which presents secondary neurological manifestations. Diabetes induces peripheral nervous system damage which is translated into impaired sensory perception and is termed diabetic neuropathy. Diabetes-related central nervous system damage causes cognitive decline. The behavioral study aimed to evaluate the effect of NAP and D-SAL on peripheral neuropathy and cognitive decline. Peripheral neuropathy was tested by measuring the response to a thermal stimulus, and cognitive ability was measured by a social memory test and a spatial memory test using long- and short-term dependent tasks and a reference memory task. Results indicated an immediate sensory neuropathy in the diabetic model, which was prevented by both peptides and a later neuropathic phase, prevented only by NAP treatment. Cognitive tests revealed impaired performance in both social and spatial memory tests in the diabetes model. Each of the peptides improved different aspects of cognitive behavior, with NAP being more potent than D-SAL. Mechanistically, both NAP and SAL contain a SIP (SxIP) domain that has been shown to interact with microtubule end-binding proteins (EBs). Specifically, we have previously shown a direct interaction of NAP with EB1 and EB3; we have further shown an interaction of the NAP-derived 4 amino acid SKIP peptide with EB3, stimulating axonal transport. Interestingly, the all D-amino acid peptide, D-SKIP, only partially mimicked SKIP activity. Our current results implicate D-SAL activity with potentially reduced potency compared to NAP, partially mimicking the SKIP/D-SKIP results and placing the SIP (SxIP) motif as a central focus for microtubule-based neuroprotection.
authors.affiliation: The Lily and Avraham Gildor Chair for the Investigation of Growth Factors, The Dr. Diana and Zelman Elton (Elbaum) Laboratory for Neuroendocrinology, Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Sagol School of Neuroscience and The Adams Super Center for Brain Studies, Tel Aviv University, Tel Aviv, 69978, Israel. igozes@post.tau.ac.il.
authors.forename: Illana
authors.initials: I
authors.lastname: Gozes
authors.affiliation: The Lily and Avraham Gildor Chair for the Investigation of Growth Factors, The Dr. Diana and Zelman Elton (Elbaum) Laboratory for Neuroendocrinology, Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Sagol School of Neuroscience and The Adams Super Center for Brain Studies, Tel Aviv University, Tel Aviv, 69978, Israel.
authors.forename: Shlomo
authors.initials: S
authors.lastname: Sragovich
authors.affiliation: The Lily and Avraham Gildor Chair for the Investigation of Growth Factors, The Dr. Diana and Zelman Elton (Elbaum) Laboratory for Neuroendocrinology, Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Sagol School of Neuroscience and The Adams Super Center for Brain Studies, Tel Aviv University, Tel Aviv, 69978, Israel.
authors.forename: Yulie
authors.initials: Y
authors.lastname: Schirer
authors.affiliation: The Lily and Avraham Gildor Chair for the Investigation of Growth Factors, The Dr. Diana and Zelman Elton (Elbaum) Laboratory for Neuroendocrinology, Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Sagol School of Neuroscience and The Adams Super Center for Brain Studies, Tel Aviv University, Tel Aviv, 69978, Israel.
authors.forename: Anat
authors.initials: A
authors.lastname: Idan-Feldman
mesh_terms: D020816:Amino Acid Motifs; D000818:Animals; D001370:Axonal Transport; D001665:Binding Sites; D003071:Cognition / Q000187:drug effects; D003929:Diabetic Neuropathies / Q000188:drug therapy*; D008297:Male; D008568:Memory / Q000187:drug effects; D008868:Microtubule Proteins / Q000378:metabolism; D009419:Nerve Tissue Proteins / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use; D059225:Nociception / Q000187:drug effects; D009842:Oligopeptides / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use; D010446:Peptide Fragments / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use; D011485:Protein Binding; D051381:Rats; D017207:Rats, Sprague-Dawley; D065853:Spatial Learning / Q000187:drug effects
chemical_list: D008868:Microtubule Proteins; D009419:Nerve Tissue Proteins; D009842:Oligopeptides; D010446:Peptide Fragments; C526732:SALLRSIPA; C425904:davunetide
keywords: ADNF (activity-dependent neurotrophic factor); ADNP (activity-dependent neuroprotective protein); D-SAL (all D-amino acid SALLRSIPA); NAP (NAPVISPQ); SIP (SxIP) the peptide motif interacting with microtubule end binding proteins
references.citation: Brain Res. 1998 Jul 27;800(1):125-35
references.pmid: 9685609
references.citation: Neurobiol Dis. 2011 Dec;44(3):327-39
references.pmid: 21827858
references.citation: Mol Psychiatry. 2016 Oct;21(10 ):1467-76
references.pmid: 26782054
references.citation: Curr Pharm Des. 2011;17(25):2603-12
references.pmid: 21728979
references.citation: J Am Chem Soc. 2001 Apr 4;123(13):3169-70
references.pmid: 11457042
references.citation: Am J Obstet Gynecol. 2006 Apr;194(4):1153-8; discussion 1158-9
references.pmid: 16580319
references.citation: J Nutr. 2001 Apr;131(4):1142-6
references.pmid: 11285316
references.citation: Eur Neuropsychopharmacol. 2011 May;21(5):355-61
references.pmid: 20598862
references.citation: J Proteomics. 2012 Jun 27;75(12):3617-29
references.pmid: 22554909
references.citation: Neurosci Biobehav Rev. 2009 Mar;33(3):205-12
references.pmid: 18761036
references.citation: Alcohol Clin Exp Res. 2007 Dec;31(12):2059-64
references.pmid: 17949468
references.citation: J Mol Neurosci. 2015 Aug;56(4):751-7
references.pmid: 26168855
references.citation: BMC Neurosci. 2008 Dec 10;9 Suppl 3:S3
references.pmid: 19091000
references.citation: J Mol Neurosci. 2006;28(3):303-7
references.pmid: 16691018
references.citation: J Neurosci Methods. 1984 May;11(1):47-60
references.pmid: 6471907
references.citation: J Biol Chem. 2001 Jan 5;276(1):708-14
references.pmid: 11013255
references.citation: J Pharmacol Exp Ther. 1998 May;285(2):619-27
references.pmid: 9580606
references.citation: Transl Psychiatry. 2015 Feb 03;5:e501
references.pmid: 25646590
references.citation: J Pharmacol Exp Ther. 2004 Jun;309(3):1183-9
references.pmid: 14762101
references.citation: Diabetologia. 2000 Apr;43(4):500-6
references.pmid: 10819245
references.citation: Physiol Behav. 1995 Aug;58(2):315-21
references.pmid: 7568435
references.citation: Obstet Gynecol. 2011 Feb;117(2 Pt 1):354-61
references.pmid: 21252750
references.citation: Nat Rev Neurosci. 2008 Jan;9(1):36-45
references.pmid: 18094705
references.citation: J Biol Chem. 2004 Jul 2;279(27):28531-8
references.pmid: 15123709
references.citation: Neuroscience. 2005;130(1):259-74
references.pmid: 15561442
references.citation: J Neurosci. 2000 Nov 1;20(21):8012-20
references.pmid: 11050122
references.citation: Hum Mol Genet. 2011 Feb 15;20(4):763-78
references.pmid: 21118899
references.citation: J Clin Invest. 1996 May 15;97(10):2299-307
references.pmid: 8636410
references.citation: Behav Brain Res. 1986 Feb;19(2):133-46
references.pmid: 3964405
references.citation: J Pharmacol Exp Ther. 2004 Jun;309(3):1190-7
references.pmid: 15007105
references.citation: PLoS One. 2012;7(12):e51458
references.pmid: 23272107
references.citation: Curr Alzheimer Res. 2007 Dec;4(5):507-9
references.pmid: 18220512
references.citation: Dev Biol. 2007 Mar 15;303(2):814-24
references.pmid: 17222401
references.citation: Neurobiol Dis. 2013 Aug;56:79-94
references.pmid: 23631872
references.citation: Diabetes Obes Metab. 2005 Sep;7(5):586-94
references.pmid: 16050952
references.citation: Nat Protoc. 2006;1(2):936-46
references.pmid: 17406327
references.citation: Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8543-8
references.pmid: 12808140
references.citation: Neurobiol Dis. 2006 Nov;24(2):384-94
references.pmid: 16935517
references.citation: Phys Chem Chem Phys. 2007 Apr 28;9(16):1895-910
references.pmid: 17431518
references.citation: Nat Genet. 2014 Apr;46(4):380-4
references.pmid: 24531329
references.citation: Neurosci Lett. 2005 Jan 3;373(1):73-8
references.pmid: 15555780
references.citation: Psychol Bull. 1976 May;83(3):482-504
references.pmid: 17582919
references.citation: J Biol Chem. 2007 Nov 23;282(47):34448-56
references.pmid: 17878164
references.citation: J Pharmacol Exp Ther. 2007 Nov;323(2):438-49
references.pmid: 17720885
references.citation: J Pharmacol Exp Ther. 2000 Jun;293(3):1091-8
references.pmid: 10869414
references.citation: Pain. 1999 Jun;81(3):307-16
references.pmid: 10431718
references.citation: J Neurochem. 2006 Aug;98(3):973-84
references.pmid: 16893427
references.citation: Behav Brain Res. 1994 Nov 16;65(1):47-55
references.pmid: 7880454
references.citation: Angew Chem Int Ed Engl. 2005 Jan 14;44(4):520-54
references.pmid: 15625667
references.citation: J Biol Chem. 2012 Nov 23;287(48):40173-85
references.pmid: 23071114
references.citation: J Neurochem. 1999 Mar;72(3):1283-93
references.pmid: 10037502
references.citation: J Pharmacol Exp Ther. 2001 May;297(2):774-9
references.pmid: 11303069
references.citation: J Alzheimers Dis. 2015;45(1):57-73
references.pmid: 25428252
references.citation: PLoS One. 2014 Jan 29;9(1):e87383
references.pmid: 24489906
references.citation: Neurosci Lett. 2008 Sep 19;442(3):267-72
references.pmid: 18619518
references.citation: Methods Mol Med. 2004;99:55-65
references.pmid: 15131329
references.citation: Mol Psychiatry. 2013 Jul;18(7):834-42
references.pmid: 23587881
references.citation: Brain Res Dev Brain Res. 1997 Apr 18;99(2):167-75
references.pmid: 9125470
references.citation: Ann N Y Acad Sci. 2000;921:115-8
references.pmid: 11193814
references.citation: Mol Psychiatry. 2014 Oct;19(10 ):1115-24
references.pmid: 25178163
references.citation: J Mol Neurosci. 1996 Winter;7(4):235-44
references.pmid: 8968945
references.citation: Mol Psychiatry. 2015 Feb;20(1):126-32
references.pmid: 24365867
references.citation: Clin Exp Pharmacol Physiol. 2006 Dec;33(12 ):1231-8
references.pmid: 17184506
references.citation: Brain Res Dev Brain Res. 2003 Aug 12;144(1):83-90
references.pmid: 12888219